EC
RYTM icon

EcoR1 Capital’s Rhythm Pharmaceuticals RYTM Stock Holding History

EcoR1 Capital’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-223,167
Closed -$4.91M – 43
2019
Q2 		$4.91M Sell
223,167
-177,671
-44% -$4.49M 0.5% 30
2019
Q1 		$11M Hold
400,838
– – 1.01% 27
2018
Q4 		$10.8M Buy
+400,838
New +$11.1M 1.08% 29
2018
Q2 		– Sell
-318,564
Closed -$6.34M – 40
2018
Q1 		$6.34M Sell
318,564
-211,597
-40% -$5.62M 0.64% 27
2017
Q4 		$15.4M Buy
+530,161
New +$14M 1.73% 14

Other funds holding RYTM

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital's RYTM Position: Q3 2019 in Review

EcoR1 Capital sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2019, closing a stake of 223,167 shares — an estimated $4.91M sold.

EcoR1 Capital first reported a position in RYTM in Q4 2017 and held it in 5 quarters. The position peaked at $15.4M in Q4 2017. 84 funds tracked by Wall St. Rank hold RYTM as of Q3 2019.

  • EcoR1 Capital reported no remaining Rhythm Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • EcoR1 Capital sold 223,167 Rhythm Pharmaceuticals shares in Q3 2019, an estimated $4.91M.
  • EcoR1 Capital first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • EcoR1 Capital's Rhythm Pharmaceuticals position peaked at $15.4M in Q4 2017.
  • 84 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2019.

Based on EcoR1 Capital's 13F filing for Q3 2019, filed 14 Nov 2019.